RE: DermaPure Allograft ( Pelvic floor surgery )28 Jan 2020 09:25
So we are a relatively small but expanding company with a range of game-changing products, that have the appropriate accreditation and licenses, support and mentoring of ARMS, in a huge market. The current share price is ridiculously low, in part to the Link selling, and maybe due to the unresolved funding. If it hasn't already got funding sorted I am sure it soon will have. Our range of products will not be allowed to fail for the sake of a relatively small amount of funding, my fear is one of the big pharmaceuticals making a bid. Exciting times!!